Changzhou Sunlight Pharmaceutical Co., Ltd., established in 1990, manufactures active pharmaceutical ingredients, chiral intermediates, fine chemicals and prophylactic biological products for markets worldwide. The company's synthesis capabilities include high-pressure catalytic hydrogenation, cryogenic reactions down to -78°C, high-pressure hydrogenolysis, Heck, Suzuki, Negishi and Sonogashira couplings, aromatic heterocyclic synthesis, rearrangement reactions, chiral resolution and Grignard reactions. Offering OEM production and CRO/CMO contract manufacturing, the company is recognized for its international approvals, experienced R&D staff, production capacity and broad product line.
No comments available.
Leave your rating & comment